Assessment of the Anticoagulation Activity of Apixaban – Reply –

Circulation Journal - Japan
doi 10.1253/circj.cj-15-0487
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Pcv108 - Prescribing Choice and the Cost of Anticoagulation in Atrial Fibrillation: A Real World Study Comparing Healthcare Expenditure With Warfarin and Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessment of Psychometric Properties of the Brazilian Version of the Oral Anticoagulation Knowledge Test

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2016English

International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

Frontiers in Pharmacology
Pharmacology
2019English

Assessment of Emergency Department Patients' Knowledge on Oral Anticoagulation Therapy

Turkish Journal of Emergency Medicine
2011English

In Reply—Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

Mayo Clinic Proceedings
Medicine
2018English

The Future of Anticoagulation

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2016English

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Reply 1: An Assessment of the Preconceptional Mitochondrial Hypothesis

British Journal of Cancer
Cancer ResearchOncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy